24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Dov Greebaum
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:28
Tech utopia or corporate overreach? The story behind the demise of Sidewalk Labs in Toronto
12:04
From Negev to NASA: Inhayle's journey to advance health safety in space
11:26
“It's tough right now in Israel, but for the Jews, it's going to be tougher in Europe over time”
11:10
"We’ll be looking out for you": Intel CEO Gelsinger stands with Israeli team
More stories
Buzz
Most popular
Daily
Weekly
1
Snyk cuts losses by a third, boosts revenue by 50%, as it prepares for IPO
2
The next Wiz? Eon raises $77M at $750M valuation before product launch
3
Intel to layoff thousands of employees in latest round of cutbacks
4
“I'd like Wix to become a $100 billion company”
5
20 Israeli climatech companies selected for UN COP29 in Baku
More news
Dov Greebaum
2 stories about Dov Greebaum
Are smart contracts actual contracts?
21.11.21
|
Dov Greenbaum
“Maybe, smart contracts can promote a new theory of contracts that would encompass not only smart contracts, but other contracts as well,” writes Dov Greenbaum
Real World Data key to drug discovery, reducing carbon footprint of clinical trials
07.11.21
|
Dov Greenbaum
"If employed effectively, the use of RWD in clinical studies has the potential to be potent in many aspects of the drug discovery and regulatory pipeline," writes Dov Greenbaum
Please ensure Javascript is enabled for purposes of
website accessibility